Cochlear implantation for treatment-induced ototoxic deafness in Langerhans cell histiocytosis. A case report

Eur Arch Otorhinolaryngol. 2005 Jun;262(6):496-500. doi: 10.1007/s00405-004-0858-1. Epub 2004 Nov 18.

Abstract

A case is presented where the authors carried out a cochlear implantation on a girl whose deafness was induced by cytostatic agents. The normally hearing child was diagnosed with Langerhans cell histiocytosis at the age of 3 years and received polychemotherapy for almost 2 years. By her 5th year, she started to develop a bilateral, progressive sensorineural hearing loss, necessitating a hearing aid in both ears. While her histiocytosis was cured, her hearing ultimately deteriorated to total deafness on the right and profound hearing loss on the left ear. After 3 years, her hearing aids no longer provided adequate hearing for the postlingually deafened girl. At the age of 14, a cochlear implantation was performed on her right ear with excellent results.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Cochlear Implantation*
  • Cochlear Implants
  • Female
  • Hearing Loss, Bilateral / chemically induced*
  • Hearing Loss, Bilateral / surgery
  • Hearing Loss, Sensorineural / chemically induced*
  • Hearing Loss, Sensorineural / surgery
  • Histiocytosis, Langerhans-Cell / drug therapy*
  • Humans
  • Speech Perception
  • Tomography, X-Ray Computed
  • Treatment Outcome